[Shorten treatment of in children severe osteomyelitis]

Area of Science:

• Pediatric infectious diseases
• Pharmacology
• Clinical treatment guidelines

Background:

• Acute staphylococcal osteomyelitis is a common bone infection in children.
• Current treatment recommendations often involve prolonged intravenous (IV) antibiotic courses (up to 6 weeks).
• Switching to oral antibiotics is typically delayed until clinical and biological parameters are stable.

Purpose of the Study:

• To evaluate the efficacy of a simplified antibiotic regimen for pediatric staphylococcal osteomyelitis.
• To explore the potential of early oral switch in antibiotic therapy.
• To identify suitable oral antibiotics based on pharmacokinetic/pharmacodynamic (PK/PD) properties.

Main Methods:

• Review of retrospective analyses and prospective non-comparative studies.
• Analysis of treatment outcomes with early oral switch strategies.
• Assessment of PK/PD profiles of oral antibiotics like clindamycin and first-generation cephalosporins.

Main Results:

• Retrospective data suggest prolonged antimicrobial courses (up to 6 weeks) are standard.
• Prospective studies indicate that initiating IV treatment and switching to oral antibiotics within a few days, using high doses, can be effective.
• Clindamycin and certain first-generation cephalosporins demonstrate favorable PK/PD parameters for early oral transition.

Conclusions:

• A simplified antibiotic regimen, involving an early switch to oral therapy, is a viable option for pediatric staphylococcal osteomyelitis.
• This approach requires careful selection of oral antibiotics with excellent PK/PD characteristics.
• Further prospective comparative studies are warranted to confirm the safety and efficacy of this simplified treatment strategy.